ArticleCPT: pharmacometrics & systems pharmacology2022

Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model-based dose-toxicity models.

Kristyn Pantoja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.